MedTrace Logo

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

NCT02067286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1642

Last updated 2016-08-31

No results posted yet for this study

Summary

The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.

Conditions

  • Influenza A
  • Influenza B
  • Respiratory Syncytial Virus (RSV)

Sponsors & Collaborators

  • Roche Molecular Systems, Inc

    collaborator INDUSTRY

  • IQuum, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02067286 on ClinicalTrials.gov